| | | | | | | | | | | | | | | | |
| |
 | Issue Date FY: 2025 ( Subtotal = $0 ) |
| 2025 | 2022 | OPENCELL TECHNOLOGIES, INC. | 4320 FOREST PARK AVE | SAINT LOUIS | MO | 63108-2979 | SAINT LOUIS CITY | USA | R44CA233153 | Establishing the POROS Intracellular Delivery System as a Platform for Cellular Therapeutics | 000 | 3 | NIH | 12/17/2024 | $0 |
|
 | Issue Date FY: 2022 ( Subtotal = $1,180,225 ) |
| 2022 | 2022 | OPENCELL TECHNOLOGIES, INC. | 4320 FOREST PARK AVE STE 303 | SAINT LOUIS | MO | 63108 | SAINT LOUIS CITY | USA | R44CA233153 | Establishing the POROS Intracellular Delivery System as a Platform for Cellular Therapeutics | 001 | 3 | NIH | 8/11/2022 | $1,180,225 |
| 2022 | 2021 | OPENCELL TECHNOLOGIES, INC. | 4320 FOREST PARK AVE STE 303 | SAINT LOUIS | MO | 63108 | SAINT LOUIS CITY | USA | R44CA233153 | Establishing the POROS Intracellular Delivery System as a Platform for Cellular Therapeutics | 000 | 2 | NIH | 1/25/2022 | $0 |
|
 | Issue Date FY: 2021 ( Subtotal = $579,886 ) |
| 2021 | 2021 | OPENCELL TECHNOLOGIES, INC. | 4320 FOREST PARK AVE STE 303 | SAINT LOUIS | MO | 63108 | SAINT LOUIS CITY | USA | R44CA233153 | Establishing the POROS Intracellular Delivery System as a Platform for Cellular Therapeutics | 000 | 2 | NIH | 9/24/2021 | $579,886 |
| 2021 | 2019 | OPENCELL TECHNOLOGIES, INC. | 4320 FOREST PARK AVE STE 303 | SAINT LOUIS | MO | 63108 | SAINT LOUIS CITY | USA | R43CA239955 | Developing a Platform for Multiplexed Large Payload Delivery | 000 | 1 | NIH | 8/26/2021 | $0 |
|
 | Issue Date FY: 2020 ( Subtotal = $0 ) |
| 2020 | 2018 | OPENCELL TECHNOLOGIES, INC. | 4320 FOREST PARK AVE STE 303 | SAINT LOUIS | MO | 63108-2979 | SAINT LOUIS CITY | USA | R43CA233153 | Establishing the POROS Intracellular Delivery System as a Platform for Cellular Therapeutics | 000 | 1 | NIH | 3/13/2020 | $0 |
|
 | Issue Date FY: 2019 ( Subtotal = $298,853 ) |
| 2019 | 2019 | OPENCELL TECHNOLOGIES, INC. | 4320 FOREST PARK AVE STE 303 | SAINT LOUIS | MO | 63108-2979 | SAINT LOUIS CITY | USA | R43CA239955 | Developing a Platform for Multiplexed Large Payload Delivery | 000 | 1 | NIH | 7/3/2019 | $298,853 |
|
 | Issue Date FY: 2018 ( Subtotal = $247,405 ) |
| 2018 | 2018 | OPENCELL TECHNOLOGIES, INC. | 4320 FOREST PARK AVE STE 303 | SAINT LOUIS | MO | 63108-2979 | SAINT LOUIS CITY | USA | R43CA233153 | Establishing the POROS Intracellular Delivery System as a Platform for Cellular Therapeutics | 000 | 1 | NIH | 9/10/2018 | $247,405 |
| 2018 | 2015 | OPENCELL TECHNOLOGIES, INC. | 4320 FOREST PARK AVE STE 303 | SAINT LOUIS | MO | 63108-2979 | SAINT LOUIS CITY | USA | R44GM112398 | MIST System for Simultaneous Parallel Intracellular Delivery & Transfection | 000 | 4 | NIH | 12/18/2017 | $0 |
|
 | Issue Date FY: 2015 ( Subtotal = $419,817 ) |
| 2015 | 2015 | OPENCELL TECHNOLOGIES INC | 311 FERST DRIVE | ATLANTA | GA | 30332 | FULTON | USA | R44GM112398 | MIST System for Simultaneous Parallel Intracellular Delivery & Transfection | 000 | 4 | NIH | 8/17/2015 | $419,817 |
|
 | Issue Date FY: 2014 ( Subtotal = $479,671 ) |
| 2014 | 2014 | OPENCELL TECHNOLOGIES INC | 311 FERST DRIVE | ATLANTA | GA | 30332 | FULTON | USA | R44GM112398 | MIST System for Simultaneous Parallel Intracellular Delivery & Transfection | 000 | 3 | NIH | 8/5/2014 | $479,671 |
|
 | Issue Date FY: 2012 ( Subtotal = $518,714 ) |
| 2012 | 2012 | OPENCELL TECHNOLOGIES INC | 311 FERST DRIVE | ATLANTA | GA | 30332 | FULTON | USA | R44GM103448 | ELECTROSONIC ACTUATION MICROARRAY: HIGH-THROUGHPUT TOOL FOR TRANSFECTION OF DIFFI | 000 | 3 | NIH | 4/4/2012 | $518,714 |
| 2012 | 2010 | OPENCELL TECHNOLOGIES INC | 311 FERST DRIVE | ATLANTA | GA | 30332 | FULTON | USA | R43RR028178 | MULTICHANNEL ELECTROSONIC ACTUATION MICROARRAY FOR CELL-BASED SCREENING | 000 | 2 | NIH | 11/7/2011 | $0 |
|
 | Issue Date FY: 2011 ( Subtotal = $486,274 ) |
| 2011 | 2011 | OPENCELL TECHNOLOGIES INC | 311 FERST DRIVE | ATLANTA | GA | 30332 | FULTON | USA | R44RR025713 | ELECTROSONIC ACTUATION MICROARRAY: HIGH-THROUGHPUT TOOL FOR TRANSFECTION OF DIFFI | 000 | 2 | NIH | 5/24/2011 | $486,274 |
| 2011 | 2010 | OPENCELL TECHNOLOGIES | 500 BISHOP STREET NORTHWEST | ATLANTA | GA | 30318 | FULTON | USA | R43RR028178 | MULTICHANNEL ELECTROSONIC ACTUATION MICROARRAY FOR CELL-BASED SCREENING | 000 | 1 | NIH | 5/23/2011 | -$85,796 |
| 2011 | 2010 | OPENCELL TECHNOLOGIES INC | 311 FERST DRIVE | ATLANTA | GA | 30332 | FULTON | USA | R43RR028178 | MULTICHANNEL ELECTROSONIC ACTUATION MICROARRAY FOR CELL-BASED SCREENING | 001 | 2 | NIH | 5/25/2011 | $85,796 |
|
 | Issue Date FY: 2010 ( Subtotal = $158,708 ) |
| 2010 | 2010 | OPENCELL TECHNOLOGIES | 500 BISHOP STREET NORTHWEST | ATLANTA | GA | 30318 | FULTON | USA | R43RR028178 | MULTICHANNEL ELECTROSONIC ACTUATION MICROARRAY FOR CELL-BASED SCREENING | 000 | 1 | NIH | 6/18/2010 | $158,708 |
| 2010 | 2009 | OPENCELL TECHNOLOGIES | 500 BISHOP STREET NORTHWEST | ATLANTA | GA | 30318 | FULTON | USA | R43RR025713 | ELECTROSONIC EJECTOR MICROARRAY FOR DEVELOPMENT OF CANCER THERAPIES | 000 | 1 | NIH | 11/6/2009 | $0 |
|
 | Issue Date FY: 2009 ( Subtotal = $120,586 ) |
| 2009 | 2009 | OPENCELL TECHNOLOGIES | 500 BISHOP STREET NORTHWEST | ATLANTA | GA | 30318 | FULTON | USA | R43RR025713 | ELECTROSONIC EJECTOR MICROARRAY FOR DEVELOPMENT OF CANCER THERAPIES | 000 | 1 | NIH | 2/12/2009 | $120,586 |
|
|